keyword
https://read.qxmd.com/read/38505552/activities-of-aztreonam-in-combination-with-several-novel-%C3%AE-lactam-%C3%AE-lactamase-inhibitor-combinations-against-carbapenem-resistant-klebsiella-pneumoniae-strains-coproducing-kpc-and-ndm
#21
JOURNAL ARTICLE
Xinhui Li, Jisheng Zhang, Jianmin Wang, Wenzhang Long, Xushan Liang, Yang Yang, Xue Gong, Jie Li, Longjin Liu, Xiaoli Zhang
Isolates coproducing serine/metallo-carbapenems are a serious emerging public health threat, given their rapid dissemination and the limited number of treatment options. The purposes of this study were to evaluate the in vitro antibacterial activity of novel β-lactam-β-lactamase inhibitor combinations (BLBLIs) against carbapenem-resistant Klebsiella pneumoniae (CRKP) coproducing metallo-β-lactamase and serine-β-lactamase, and to explore their effects in combination with aztreonam, meropenem, or polymyxin in order to identify the best therapeutic options...
2024: Frontiers in Microbiology
https://read.qxmd.com/read/38504262/global-mapping-of-antibiotic-resistance-rates-among-clinical-isolates-of-stenotrophomonas-maltophilia-a-systematic-review-and-meta-analysis
#22
REVIEW
Narjess Bostanghadiri, Mohammad Sholeh, Tahereh Navidifar, Leila Dadgar-Zankbar, Zahra Elahi, Alex van Belkum, Davood Darban-Sarokhalil
INTRODUCTION: Infections caused by Stenotrophomonas maltophilia are clinically important due to its intrinsic resistance to a broad range of antibiotics. Therefore, selecting the most appropriate antibiotic to treat S. maltophilia infection is a major challenge. AIM: The current meta-analysis aimed to investigate the global prevalence of antibiotic resistance among S. maltophilia isolates to the develop more effective therapeutic strategies. METHOD: A systematic literature search was performed using the appropriate search syntax after searching Pubmed, Embase, Web of Science and Scopus databases (May 2023)...
March 19, 2024: Annals of Clinical Microbiology and Antimicrobials
https://read.qxmd.com/read/38501368/in-vitro-activity-of-apramycin-ebl-1003-in-combination-with-colistin-meropenem-minocycline-or-sulbactam-against-xdr-pdr-acinetobacter-baumannii-isolates-from-greece
#23
JOURNAL ARTICLE
I Galani, M Souli, D Katsala, I Karaiskos, H Giamarellou, A Antoniadou
OBJECTIVES: To evaluate the in vitro activity of the combination of apramycin with colistin, meropenem, minocycline or sulbactam, against some well-characterized XDR Acinetobacter baumannii clinical isolates from Greece, to understand how apramycin can be best incorporated into clinical practice and optimize effectiveness. METHODS: In vitro interactions of apramycin (0.5×, 1× and 2× the MIC value) with colistin (2 mg/L), meropenem (30 mg/L), minocycline (3...
March 19, 2024: Journal of Antimicrobial Chemotherapy
https://read.qxmd.com/read/38500714/the-prevalence-of-gram-negative-bacteria-with-difficult-to-treat-resistance-and-utilization-of-novel-%C3%AE-lactam-antibiotics-in-the-southeastern-united-states
#24
JOURNAL ARTICLE
Y Vivian Tsai, P Brandon Bookstaver, Joseph Kohn, Julie Ann Justo, Darrell Childress, Stefanie Stramel, Douglas Slain, Patrick Tu, Mary Joyce B Wingler, Bruce M Jones, Daniel T Anderson, Megan M Seddon, David A Cretella, Joshua Eudy, Hana Winders, Kayla Antosz, Pamela Bailey, Majdi N Al-Hasan
OBJECTIVE: To evaluate temporal trends in the prevalence of gram-negative bacteria (GNB) with difficult-to-treat resistance (DTR) in the southeastern United States. Secondary objective was to examine the use of novel β-lactams for GNB with DTR by both antimicrobial use (AU) and a novel metric of adjusted AU by microbiological burden (am-AU). DESIGN: Retrospective, multicenter, cohort. SETTING: Ten hospitals in the southeastern United States...
2024: Antimicrob Steward Healthc Epidemiol
https://read.qxmd.com/read/38484641/spider-chart-greenness-and-whiteness-assessment-of-experimentally-designed-multivariate-models-for-simultaneous-determination-of-three-drugs-used-as-a-combinatory-antibiotic-regimen-in-critical-care-units-comparative-study
#25
JOURNAL ARTICLE
Asmaa M Taha, Manal S Elmasry, Wafaa S Hassan, Rania A Sayed
In this study, five earth-friendly spectrophotometric methods using multivariate techniques were developed to analyze levofloxacin, linezolid, and meropenem, which are utilized in critical care units as combination therapies. These techniques were used to determine the mentioned medications in laboratory-prepared mixtures, pharmaceutical products and spiked human plasma that had not been separated before handling. These methods were named classical least squares (CLS), principal component regression (PCR), partial least squares (PLS), genetic algorithm partial least squares (GA-PLS), and artificial neural network (ANN)...
March 4, 2024: Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy
https://read.qxmd.com/read/38455208/evaluating-enterococcus-faecium-9%C3%A2-n-2-as-a-probiotic-candidate-from-traditional-village-white-cheese
#26
JOURNAL ARTICLE
Neslihan Dikbaş, Yusuf Can Orman, Şeyma Alım, Sevda Uçar, Ahmet Tülek
In this study, various functional and probiotic attributes of the Enterococcus faecium 9 N-2 strain isolated from village-style white cheese were characterized, while also assessing its safety. To achieve this, we conducted an in vitro analysis of several key probiotic properties exhibited by the 9 N-2 strain. Notably, this strain demonstrated robust resilience to low pH, high bile salt concentrations, lysozyme, pepsin, pancreatin, and phenol. Furthermore, this strain displayed exceptional auto-aggregation capabilities and moderate co-aggregation tendencies when interacting with Escherichia coli ...
March 2024: Food Science & Nutrition
https://read.qxmd.com/read/38453704/validation-of-a-stenotrophomonas-maltophilia-bloodstream-infection-prediction-score-in-the-hematologic-malignancy-population
#27
JOURNAL ARTICLE
Emily L Gill, Christian M Gill, Colleen McEvoy
Stenotrophomonas maltophilia (SM) bloodstream infections (BSIs) contribute to significant mortality in hematologic malignancy (HM) and hematopoietic stem cell transplantation (HSCT) patients. A risk score to predict SM BSI could reduce time to appropriate antimicrobial therapy (TTAT) and improve patient outcomes. A single center cohort study of hospitalized adults with HM/HSCT was conducted. Patients had ≥ 1 blood culture with a Gram-negative (GN) organism. A StenoSCORE was calculated for each patient...
March 8, 2024: Annals of Hematology
https://read.qxmd.com/read/38438932/combination-of-a-multiplex-pneumonia-panel-and-gram-staining-for-antimicrobial-selection-to-treat-lower-respiratory-tract-infection
#28
JOURNAL ARTICLE
Hiroshi Matsuura, Koudai Arimoto, Yoshihito Takahashi, Masafumi Kishimoto
AIM: This study aimed to examine the utility of simultaneously performed the Film Array pneumonia panels (pneumonia panels) and Gram staining with the same specimens and evaluate their effect on antimicrobial selection. METHODS: This prospective study, conducted from April 2022 to January 2023, enrolled adult patients with pneumonia, including those with ventilator-associated pneumonia (VAP). Specimens obtained at the time of sputum culture were tested using Gram staining and the pneumonia panel...
March 5, 2024: Pneumonia
https://read.qxmd.com/read/38431235/inhibition-of-the-bla-oxa-48-gene-expression-in-klebsiella-pneumoniae-by-a-plasmid-carrying-crispri-cas9-system
#29
JOURNAL ARTICLE
Yeganeh Hajizadeh, Farzad Badmasti, Mana Oloomi
Antibiotic resistance is an increasing concern that threatens the effectiveness of treating bacterial infections. The spread of carbapenem resistant Klebsiella pneumoniae poses a significant threat to global public health. To combat this issue, the clustered regularly interspaced short palindromic repeats interference (CRISPRi) system is being developed. This system includes a single guide RNA (sgRNA) and a nuclease dead Cas9 (dCas9), which work together to downregulate gene expression. Our project involved the use of the CRISPRi system to reduce gene expression of the beta-lactamase oxacillin-48 (blaOXA-48 ) gene in K...
March 1, 2024: Gene
https://read.qxmd.com/read/38413891/phenotypic-molecular-and-in-silico-characterization-of-coumarin-as-carbapenemase-inhibitor-to-fight-carbapenem-resistant-klebsiella-pneumoniae
#30
JOURNAL ARTICLE
Mahmoud Saad Abdel-Halim, Amira M El-Ganiny, Basem Mansour, Galal Yahya, Hemat K Abd El Latif, Momen Askoura
BACKGROUND: Carbapenems represent the first line treatment of serious infections caused by drug-resistant Klebsiella pneumoniae. Carbapenem-resistant K. pneumoniae (CRKP) is one of the urgent threats to human health worldwide. The current study aims to evaluate the carbapenemase inhibitory potential of coumarin and to test its ability to restore meropenem activity against CRKP. Disk diffusion method was used to test the antimicrobial susceptibility of K. pneumoniae clinical isolates to various antibiotics...
February 27, 2024: BMC Microbiology
https://read.qxmd.com/read/38402083/repurposing-dnase-i-and-alginate-lyase-to-degrade-the-biofilm-matrix-of-dual-species-biofilms-of-staphylococcus-aureus-and-pseudomonas-aeruginosa-grown-in-artificial-sputum-medium-in-vitro-assessment-of-their-activity-in-combination-with-broad-spectrum-antibiotics
#31
JOURNAL ARTICLE
Zhifen Wang, Rita Vanbever, Joseph H Lorent, Jessica Solis, Christiane Knoop, Françoise Van Bambeke
BACKGROUND: Biofilm-associated pulmonary infections pose therapeutic challenges in cystic fibrosis patients, especially when involving multiple bacterial species. Enzymatic degradation of the biofilm matrix may offer a potential solution to enhance antibiotic efficacy. This study investigated the repurposing of DNase I, commonly used for its mucolytic activity in cystic fibrosis, to target extracellular DNA within biofilms, as well as potential synergies with alginate lyase and broad-spectrum antibiotics in dual-species biofilms of Pseudomonas aeruginosa and Staphylococcus aureus...
February 23, 2024: Journal of Cystic Fibrosis: Official Journal of the European Cystic Fibrosis Society
https://read.qxmd.com/read/38399472/carbapenems-as-antidotes-for-the-management-of-acute-valproic-acid-poisoning
#32
JOURNAL ARTICLE
Nataša Perković Vukčević, Vesna Mijatović Jovin, Gordana Vuković Ercegović, Marko Antunović, Igor Kelečević, Dejan Živanović, Slavica Vučinić
INTRODUCTION: Valproic acid (VPA) is a broad-spectrum drug primarily used in the treatment of epilepsy and bipolar disorder. It is not an uncommon occurrence for VPA to cause intoxication. The established treatment of VPA poisoning includes supportive care, multiple doses of activated charcoal, levocarnitine and hemodialysis/hemoperfusion. There is a clinically significant interaction between carbapenem antibiotics and VPA. By affecting enterohepatic recirculation, carbapenems can increase the overall VPA clearance from the blood of intoxicated patients...
February 17, 2024: Pharmaceuticals
https://read.qxmd.com/read/38391550/extended-infusion-of-beta-lactams-and-glycopeptides-a-new-era-in-pediatric-care-a-systematic-review-and-meta-analysis
#33
REVIEW
Andrea Rahel Burch, Lukas von Arx, Barbara Hasse, Vera Neumeier
Optimizing antibiotic therapy is imperative with rising bacterial resistance and high infection mortality. Extended infusion defined as a continuous infusion (COI) or prolonged infusion (PI) of beta-lactams and glycopeptides might improve efficacy and safety compared to their intermittent administration (IA). This study aimed to evaluate the efficacy and safety of extended infusion in pediatric patients. Adhering to Cochrane standards, we conducted a systematic review with meta-analysis investigating the efficacy and safety of COI (24 h/d) and PI (>1 h/dose) compared to IA (≤1 h/dose) of beta-lactams and glycopeptides in pediatrics...
February 7, 2024: Antibiotics
https://read.qxmd.com/read/38391512/in-vitro-activity-of-old-and-new-antimicrobials-against-the-klebsiella-pneumoniae-complex
#34
JOURNAL ARTICLE
Alicja Sękowska
The Klebsiella pneumoniae complex is a commonly isolated bacteria in human infections. These opportunistic pathogens pose a serious threat to public health due to their potential transmission to the human population. Resistance to carbapenems is a significant antimicrobial resistance mechanism, leading to limited therapeutic options. Therefore, the aim of this study was to evaluate the in vitro activity of fosfomycin, colistin, ceftazidime-avibactam, and meropenem-vaborbactam against multidrug-resistant K. pneumoniae complex strains...
January 26, 2024: Antibiotics
https://read.qxmd.com/read/38383758/the-synergic-and-addictive-activity-of-biogenic-silver-nanoparticle-bio-agnp-associated-with-meropenem-against-carbapenem-resistant-acinetobacter-baumannii
#35
JOURNAL ARTICLE
Suzane Olachea Allend, Marcelle de Oliveira Garcia, Kamila Furtado Cunha, Déborah Trota Faria Albernaz, Luciano Aparecido Panagio, Gerson Nakazaro, Guilherme Fonseca Reis, Thaís Larré Oliveira, Amilton Clair Pinto Seixas Neto, Daiane Drawanz Hartwig
AIMS: Antibiotic management of infections caused by Acinetobacter baumannii often fails due to antibiotic resistance (especially to carbapenems) and biofilm-forming strains. Thus, the objective here was to evaluate in vitro the antibacterial and antibiofilm activity of biogenic silver nanoparticle (Bio-AgNP) combined with meropenem, against multidrug-resistant (MDR) isolates of A. baumannii. METHODS AND RESULTS: In this study, A. baumannii ATCC® 19606™ and four carbapenem-resistant A...
February 21, 2024: Journal of Applied Microbiology
https://read.qxmd.com/read/38372558/a-prospective-quasi-experimental-study-of-multifaceted-interventions-including-computerized-drug-utilization-evaluation-to-improve-an-antibiotic-stewardship-program
#36
JOURNAL ARTICLE
Sunudtha Suksamai, Sirinporn Sajak, Kanokporn Thongphubeth, Thana Khawcharoenporn
OBJECTIVE: This study aimed to determine and evaluate interventions that improve an antibiotic stewardship program (ASP) in reduction of the amount of antibiotic use and errors in drug utilization evaluation (DUE) form completion. METHODS: A prospective quasi-experimental study was conducted to evaluate the effectiveness of the multifaceted interventions (preauthorization with computerized DUE, self-supervised checklists, and short active reminders of the antibiotic guidelines recommendations) incorporating an ASP among hospitalized internal medicine patients in a Thai tertiary care center...
February 16, 2024: Journal of Patient Safety
https://read.qxmd.com/read/38352887/predictors-of-antibiogram-performance-and-antibiotic-resistance-patterns-in-the-northern-syrian-region-a-cross-sectional-investigation
#37
JOURNAL ARTICLE
Nour Bourgi, Abd Alrahman Olaby, Ali Najdi, Georges Hatem
INTRODUCTION: Antibiogram use is crucial in the fight against antibiotic resistance in Syria, helping to guide treatment decisions, monitor resistance trends, and implement measures to mitigate this global health threat. This study explores the predictors of antibiogram performance and antibiotic resistance patterns in hospital settings in the Northern Syrian region. METHODS: An observational cross-sectional study was performed over six months, from the beginning of September 2022 to February 2023, targeting patients admitted to two hospitals in Syria with susceptibility to infection...
March 2024: Explor Res Clin Soc Pharm
https://read.qxmd.com/read/38329626/enterobacter-cloacae-from-urinary-tract-infections-frequency-protein-analysis-and-antimicrobial-resistance
#38
JOURNAL ARTICLE
Ayman Elbehiry, Mansor Al Shoaibi, Hamzah Alzahrani, Mai Ibrahem, Ihab Moussa, Feras Alzaben, Rousa A Alsubki, Hassan A Hemeg, Dakheel Almutairi, Saleh Althobaiti, Fawaz Alanazi, Sultan A Alotaibi, Hamoud Almutairi, Ali Alzahrani, Akram Abu-Okail
The genus Enterobacter belongs to the ESKAPE group, which includes Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp. This group is characterized by the development of resistance to various antibiotics. In recent years, Enterobacter cloacae (E. cloacae) has emerged as a clinically important pathogen responsible for a wide range of healthcare-associated illnesses. Identifying Enterobacter species can be challenging due to their similar phenotypic characteristics...
February 8, 2024: AMB Express
https://read.qxmd.com/read/38321472/qsofa-combined-with-supar-for-early-risk-detection-and-guidance-of-antibiotic-treatment-in-the-emergency-department-a-randomized-controlled-trial
#39
RANDOMIZED CONTROLLED TRIAL
Maria Evangelia Adami, Antigone Kotsaki, Nikolaos Antonakos, Efthymia Giannitsioti, Stamatios Chalvatzis, Maria Saridaki, Christina Avgoustou, Karolina Akinosoglou, Konstantina Dakou, Georgia Damoraki, Konstantina Katrini, Panagiotis Koufargyris, Vasileios Lekakis, Antonia Panagaki, Asimina Safarika, Jesper Eugen-Olsen, Evangelos J Giamarellos-Bourboulis
BACKGROUND: Sepsis guidelines suggest immediate start of resuscitation for patients with quick Sequential Organ Failure Assessment (qSOFA) 2 or 3. However, the interpretation of qSOFA 1 remains controversial. We investigated whether measurements of soluble urokinase plasminogen activator receptor (suPAR) may improve risk detection when qSOFA is 1. METHODS: The study had two parts. At the first part, the combination of suPAR with qSOFA was analyzed in a prospective cohort for early risk detection...
February 6, 2024: Critical Care: the Official Journal of the Critical Care Forum
https://read.qxmd.com/read/38319075/simulated-drug-disposition-in-critically-ill-patients-to-evaluate-effective-pk-pd-targets-for-combating-pseudomonas-aeruginosa-resistance-to-meropenem
#40
JOURNAL ARTICLE
Xiaonan Zhang, Yan Wang, Sanwang Li, Feifan Xie, Hanxi Yi
Bacterial infections, including those caused by Pseudomonas aeruginosa , often lead to sepsis, necessitating effective antibiotic treatment like carbapenems. The key pharmacokinetic/pharmacodynamic (PK/PD) index correlated to carbapenem efficacy is the fraction time of unbound plasma concentration above the minimum inhibitory concentration (MIC) of the pathogen (% fT > MIC). While multiple targets exist, determining the most effective one for critically ill patients remains a matter of debate. This study evaluated meropenem's bactericidal potency and its ability to combat drug resistance in Pseudomonas aeruginosa under three representative PK/PD targets: 40% fT > MIC, 100% fT > MIC, and 100% fT > 4× MIC...
February 6, 2024: Antimicrobial Agents and Chemotherapy
keyword
keyword
108043
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.